@article{630f0386ea3a4ba1a99d2b6e69bcdcd9,
title = "Management of Anaplastic and Recurrent Differentiated Thyroid Cancer: Indications for Surgical Resection, Molecular Testing, and Systemic Therapy",
keywords = "BRAF, Kinase inhibitor, MEK, NTRK, RET",
author = "Cabanillas, {Maria E.} and Salmaan Ahmed and Wang, {Jennifer Rui}",
note = "Funding Information: Dr M.E. Cabanillas has received grant funding from Eisai, Exelixis, Genentech, Merck and Kura. Advisory boards: exelixis, blueprint, Ignyta, Bayer and LOXO. The other authors have nothing to disclose.",
year = "2021",
month = aug,
doi = "10.1016/j.nic.2021.04.005",
language = "English (US)",
volume = "31",
pages = "359--366",
journal = "Neuroimaging Clinics of North America",
issn = "1052-5149",
publisher = "W.B. Saunders Ltd",
number = "3",
}